The objective of this project is to define the mechanism controlling cholesterol deposition and mobilization in foam cells the presence of foam cells is a hallmark of atherosclerosis. The foam-cell phenotype results from the formation of numerous cytoplasmic neutral lipid droplets or inclusions, consisting mostly of cholesteryl ester (CE). This CE undergoes a continuous cycle of hydrolysis and re-esterification mediated by neutral cholesteryl ester hydrolases and acyl-CoA: cholesterol acyl transferase. Project 3 will examine several poorly understood aspects of cholesterol metabolism in model macrophage foam cells, with a particular focus on the metabolism of CE.
The Specific Aims are: 1) To elucidate the structure and formation of inclusions by studies of their composition, with particular attention to the surface proteins and phospholipids, and by studies of the mechanism of incorporation of CE synthesized in the endoplasmic reticulum into inclusions. 2) To examine the control of CE hydrolysis, by identification and molecular cloning of lipases with potential involvement in CE metabolism, and determining the effects of altered expression of these lipases and other components of the droplet surface identified under Aim 1. 3) To determine the intracellular locations of the free cholesterol generated by cytoplasmic CE hydrolysis, and to examine how this localization is affected by agents that perturb sterol trafficking and vesicular transport. 4) To establish the metabolic consequences of the accumulation of cholesterol produced CD hydrolysis, and to compare these responses to those provoked by direct uptake of exogenous cholesterol via the plasma membrane. The information gained in these studies will be relevant to the pathological events in the progression and regression of atherosclerosis, and will aid the development of prevention and treatment protocols.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
7P01HL022633-22
Application #
6296858
Study Section
Project Start
1998-11-11
Project End
1999-06-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
22
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Mcp Hahnemann University
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19102
Cuchel, Marina; Raper, Anna C; Conlon, Donna M et al. (2017) A novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humans. J Lipid Res 58:752-762
Nagao, Kohjiro; Hata, Mami; Tanaka, Kento et al. (2014) The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles. Biochim Biophys Acta 1841:80-7
Weibel, Ginny L; Drazul-Schrader, Denise; Shivers, Debra K et al. (2014) Importance of evaluating cell cholesterol influx with efflux in determining the impact of human serum on cholesterol metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 34:17-25
Phillips, Michael C (2014) Molecular mechanisms of cellular cholesterol efflux. J Biol Chem 289:24020-9
Yang, Yanbo; Kuwano, Takashi; Lagor, William R et al. (2014) Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species. Lipids 49:505-15
Lagor, William R; Fields, David W; Bauer, Robert C et al. (2014) Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosis. Atherosclerosis 233:234-41
Chetty, Palaniappan Sevugan; Nguyen, David; Nickel, Margaret et al. (2013) Comparison of apoA-I helical structure and stability in discoidal and spherical HDL particles by HX and mass spectrometry. J Lipid Res 54:1589-97
Nguyen, David; Nickel, Margaret; Mizuguchi, Chiharu et al. (2013) Interactions of apolipoprotein A-I with high-density lipoprotein particles. Biochemistry 52:1963-72
Alexander, Eric T; Phillips, Michael C (2013) Influence of apolipoprotein A-I and apolipoprotein A-II availability on nascent HDL heterogeneity. J Lipid Res 54:3464-70
Patel, Parin J; Khera, Amit V; Wilensky, Robert L et al. (2013) Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy. Eur J Heart Fail 15:1215-9

Showing the most recent 10 out of 336 publications